Adaptive Biotechnologies Corp ADPT
News
Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results
Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
